Abiopharma

🔍 Talasaz AmirAli (Director)

Company: Guardant Health, Inc. (GH)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 111,804 shares of Common Stock at $4.18 per share (Direct)
  Date: 2026-06-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,998,308.00 | transaction_form_type: 4
• Sold 64,037 shares of Common Stock at $150.4886 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,934,271.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 52,935 shares of Common Stock at $151.1595 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,881,336.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 143,028 shares of Common Stock at $4.18 per share (Direct)
  Date: 2026-06-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,024,364.00 | transaction_form_type: 4
• Sold 25,812 shares of Common Stock at $150.5282 per share (Direct)
  Date: 2026-06-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,998,552.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 70,513 shares of Common Stock at $151.4659 per share (Direct)
  Date: 2026-06-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,928,039.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 46,663 shares of Common Stock at $152.2045 per share (Direct)
  Date: 2026-06-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,881,376.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 40 shares of Common Stock at $153.0 per share (Direct)
  Date: 2026-06-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,881,336.00 | transaction_form_type: 4
• Sold 111,804 shares of Stock Option (Right to Buy) at $4.18 per share (Derivative)
  Date: 2026-06-26 | Code: M | Expires: 2027-07-14 | equity_swap_involved: 0 | shares_owned_after: 172,025.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 143,028 shares of Stock Option (Right to Buy) at $4.18 per share (Derivative)
  Date: 2026-06-29 | Code: M | Expires: 2027-07-14 | equity_swap_involved: 0 | shares_owned_after: 28,997.00 | transaction_form_type: 4 | Footnotes: F5

Footnotes:

• F1: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F2: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.00 to $151.79. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F3: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.00 to $151.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F4: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $152.00 to $152.68. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
• F5: The stock option vested in equal monthly installments over 48 months commencing on April 23, 2017.